These findings should motivate to persist with the diagnostics—i.e., involve a research laboratory for further serological testing—when the clinical suspicion of anti-CASPR2-/LGI1-encephalitis remains high despite negative diagnostics. This evidence concerns the gene CNTNAP2 and encephalitis.